131 related articles for article (PubMed ID: 25075072)
21. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer.
Lindegaard JC; Assenholt M; Ramlov A; Fokdal LU; Alber M; Tanderup K
Acta Oncol; 2017 Nov; 56(11):1479-1486. PubMed ID: 28849684
[TBL] [Abstract][Full Text] [Related]
22. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
[TBL] [Abstract][Full Text] [Related]
23. Intensity-modulated radiation therapy versus para-aortic field radiotherapy to treat para-aortic lymph node metastasis in cervical cancer: prospective study.
Du XL; Sheng XG; Jiang T; Yu H; Yan YF; Gao R; Lu CH; Li QS
Croat Med J; 2010 Jun; 51(3):229-36. PubMed ID: 20564766
[TBL] [Abstract][Full Text] [Related]
24. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
Folkert MR; Shih KK; Abu-Rustum NR; Jewell E; Kollmeier MA; Makker V; Barakat RR; Alektiar KM
Gynecol Oncol; 2013 Feb; 128(2):288-93. PubMed ID: 23159818
[TBL] [Abstract][Full Text] [Related]
25. Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies.
Boyle J; Craciunescu O; Steffey B; Cai J; Chino J
Gynecol Oncol; 2014 Nov; 135(2):239-43. PubMed ID: 25192879
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.
Yin Z; Lou H; Tang H; Ni J; Zhou Q; Chen M
Radiat Oncol; 2019 May; 14(1):82. PubMed ID: 31109371
[TBL] [Abstract][Full Text] [Related]
27. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes using adjuvant pelvic intensity modulated radiation therapy (IMRT) for endometrial carcinoma.
He S; Gill BS; Heron DE; Kelley JL; Sukumvanich P; Olawaiye AB; Edwards RP; Comerci J; Beriwal S
Pract Radiat Oncol; 2017; 7(1):19-25. PubMed ID: 27527897
[TBL] [Abstract][Full Text] [Related]
29. High dose simultaneous integrated boost for node positive cervical cancer.
Jayatilakebanda I; Tsang YM; Hoskin P
Radiat Oncol; 2021 May; 16(1):92. PubMed ID: 34001158
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma.
Kodaira T; Fuwa N; Nakanishi T; Tachibana H; Nakamura T; Tomita N; Nakahara R; Inokuchi H
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):251-8. PubMed ID: 18513885
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
[TBL] [Abstract][Full Text] [Related]
32. [Extended-field intensity modulated radiation therapy and intra-cavitary brachytherapy combined with chemotherapy for stage Ib1-IVa cervical cancer with positive para-aortic lymph nodes].
Ke GH; Huang X; Huang XW; Liu SP; Wu XH
Zhonghua Fu Chan Ke Za Zhi; 2013 Sep; 48(9):649-53. PubMed ID: 24332129
[TBL] [Abstract][Full Text] [Related]
33. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
Gandhi AK; Sharma DN; Rath GK; Julka PK; Subramani V; Sharma S; Manigandan D; Laviraj MA; Kumar S; Thulkar S
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):542-8. PubMed ID: 24074927
[TBL] [Abstract][Full Text] [Related]
34. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
[TBL] [Abstract][Full Text] [Related]
35. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome.
Kim JW; Cho JH; Keum KC; Kim JH; Kim GE; Lee JY; Kim SK; Lee CG
Jpn J Clin Oncol; 2012 Dec; 42(12):1152-60. PubMed ID: 23077243
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.
Hodges JC; Das P; Eng C; Reish AG; Beddar AS; Delclos ME; Krishnan S; Crane CH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):791-4. PubMed ID: 19231109
[TBL] [Abstract][Full Text] [Related]
37. Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
Lee J; Lin JB; Chang CL; Sun FJ; Wu MH; Jan YT; Chen YJ
Gynecol Oncol; 2018 Feb; 148(2):291-298. PubMed ID: 29269219
[TBL] [Abstract][Full Text] [Related]
38. Dose escalation by intensity-modulated radiotherapy boost after whole pelvic radiotherapy in postoperative patients of carcinoma cervix with residual disease.
Khosla D; Patel FD; Rai B; Chakraborty S; Oinam AS; Sharma SC
Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):e1-6. PubMed ID: 22889568
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer].
Gao K; Ding L; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):30-5. PubMed ID: 24694915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
